miRagen Therapeutics, Inc.-Product Pipeline Review-2015

miRagen Therapeutics, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07199CDB
  • |
  • Pages: 28
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

miRagen Therapeutics, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'miRagen Therapeutics, Inc.-Product Pipeline Review-2015', provides an overview of the miRagen Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of miRagen Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of miRagen Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of miRagen Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the miRagen Therapeutics, Inc.'s pipeline products

Reasons To Buy

Evaluate miRagen Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of miRagen Therapeutics, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the miRagen Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of miRagen Therapeutics, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of miRagen Therapeutics, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of miRagen Therapeutics, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

miRagen Therapeutics, Inc. Snapshot 5

miRagen Therapeutics, Inc. Overview 5

Key Information 5

Key Facts 5

miRagen Therapeutics, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

miRagen Therapeutics, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

miRagen Therapeutics, Inc.-Pipeline Products Glance 10

miRagen Therapeutics, Inc.-Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

miRagen Therapeutics, Inc.-Drug Profiles 11

MGN-1374 11

Product Description 11

Mechanism of Action 11

R&D Progress 11

MGN-4220 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

MGN-4893 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

MGN-6114 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

MGN-9103 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

MRG-106 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

MRG-107 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Oligonucleotide for Cardiovascular Disease 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Oligonucleotide to Inhibit miR-145 for PAH 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

miRagen Therapeutics, Inc.-Pipeline Analysis 20

miRagen Therapeutics, Inc.-Pipeline Products by Target 20

miRagen Therapeutics, Inc.-Pipeline Products by Molecule Type 21

miRagen Therapeutics, Inc.-Pipeline Products by Mechanism of Action 22

miRagen Therapeutics, Inc.-Recent Pipeline Updates 23

miRagen Therapeutics, Inc.-Dormant Projects 25

miRagen Therapeutics, Inc.-Locations And Subsidiaries 26

Head Office 26

Appendix 27

Methodology 27

Coverage 27

Secondary Research 27

Primary Research 27

Expert Panel Validation 27

Contact Us 27

Disclaimer 28

List of Tables

miRagen Therapeutics, Inc., Key Information 5

miRagen Therapeutics, Inc., Key Facts 5

miRagen Therapeutics, Inc.-Pipeline by Indication, 2015 7

miRagen Therapeutics, Inc.-Pipeline by Stage of Development, 2015 8

miRagen Therapeutics, Inc.-Monotherapy Products in Pipeline, 2015 9

miRagen Therapeutics, Inc.-Preclinical, 2015 10

miRagen Therapeutics, Inc.-Pipeline by Target, 2015 20

miRagen Therapeutics, Inc.-Pipeline by Molecule Type, 2015 21

miRagen Therapeutics, Inc.-Pipeline Products by Mechanism of Action, 2015 22

miRagen Therapeutics, Inc.-Recent Pipeline Updates, 2015 23

miRagen Therapeutics, Inc.-Dormant Developmental Projects,2015 25

List of Figures

miRagen Therapeutics, Inc.-Pipeline by Top 10 Indication, 2015 7

miRagen Therapeutics, Inc.-Pipeline by Top 10 Target, 2015 20

miRagen Therapeutics, Inc.-Pipeline by Top 10 Molecule Type, 2015 21

miRagen Therapeutics, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of miRagen Therapeutics, Inc.; miRagen Therapeutics, Inc. - Key Therapeutics; miRagen Therapeutics, Inc. - Pipeline Overview and Promising Molecules; miRagen Therapeutics, Inc. - News; miRagen Therapeutics, Inc. - Latest Updates; miRagen Therapeutics, Inc. - Pipeline; miRagen Therapeutics, Inc. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101175
Site License
USD 3000 INR 202350
Corporate User License
USD 4500 INR 303525



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com